-
Innovation Ranking
NewInnovation Ranking – Alcon Inc
Alcon Inc (Alcon) is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables and surgical equipment. The company's products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases and refractive errors. It conducts clinical trials to evaluate the safety and efficacy of its products for prevention and cure of blindness and different eye diseases. Alcon’s pipeline products are developed...
-
Product Insights
Alcon Biomass Power Plant
Alcon Biomass Power Plant is a biopower project located in Brazil. The project is owned and developed by Alcon Companhia de Alcool Conceicao da Barra. The project came online in 2018. Empower your strategies with our Alcon Biomass Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Sector Analysis
NewIntraocular Lens (IOL) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Intraocular Lens (IOL) Market Report Overview The intraocular lens (IOL) market was valued at $4.48 billion in 2023 and the market will grow at more than 2% during 2023-2033. The rising prevalence of cataracts and refractive error coupled with the increasing population around the globe has compelled governments to start initiatives toward lowering the number of patients suffering from partial or complete blindness. This, in turn, will lead to an increase in the number of eye surgeries and the use...
-
Company Insights
Innovation and Patenting activity of Alcon Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Alcon Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Sector Analysis
NewOphthalmic Viscoelastic Devices (OVD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Ophthalmic Viscoelastic Devices (OVD) Market Report Overview The ophthalmic viscoelastic devices (OVD) market size was $1.2 billion in 2023. The market will grow at a CAGR of more than 2% during 2023-2033. Ophthalmic viscoelastic devices, also known as OVDs, are devices used during intraocular surgery, especially anterior segment surgery. These are the viscoelastic materials used to maintain space in the eye during surgery. Typically, OVDs are pre-packaged in a syringe and are applied using a small tube. Essential properties of...
-
Product Insights
Glaucoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Glaucoma Clinical Trial Report Overview A total of 1,696 glaucoma clinical trials were conducted as of January 2024. The glaucoma clinical trial report provides a comprehensive understanding of the glaucoma clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       Europe ·       North America ·       ...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Transitional Cell Cancer (Urothelial Cell Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Transitional Cell Cancer (Urothelial Cell Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Transitional Cell Cancer (Urothelial Cell Cancer)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Axitinib SR in Wet (Neovascular / Exudative) Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Axitinib SR in Wet (Neovascular / Exudative) Macular Degeneration report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Axitinib SR in Wet (Neovascular / Exudative)...
-
Sector Analysis
Ophthalmic Lasers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Ophthalmic Lasers Market Report Overview The ophthalmic lasers market size was $1.12 billion in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. Ophthalmic lasers create a uniform and coherent light that can be continuous or pulsed. The devices are used in treating a wide spectrum of diseases involving both the anterior and posterior segments of the eye for correcting refractive disorders. Ophthalmic Lasers Market Outlook, 2023-2033 ($ Billion) Â Buy the Full Report...
-
Sector Analysis
Glaucoma Surgery Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Glaucoma Surgery Devices Market Report Overview The glaucoma surgery devices market size was $373.2 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways to provide effective intra-ocular pressure. Glaucoma drainage devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow. Glaucoma...